Maravai LifeSciences Holdings

Traded on the St. Petersburg Stock Exchange
Maravai LifeSciences Holdings is an American holding company that focuses on providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Maravai LifeSciences Holdings was incorporated in 2020 and is headquartered in San Diego, California.
Maravai LifeSciences Holdings stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Maravai LifeSciences Holdings balance sheet

Report period2019 2020 2021 2022 2023 Q2 24
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Maravai LifeSciences Holdings cash flows

Report period2019 2020 2021 2022 2023 Q2 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Maravai LifeSciences Holdings multipliers

Report period2019 2020 2021 2022 2023 Q2 24 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Maravai LifeSciences Holdings profitability

Report period2019 2020 2021 2022 2023 Q2 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Maravai LifeSciences Holdings assets
Maravai LifeSciences Holdings cash flows

Maravai LifeSciences Holdings dividend policy

The company doesn't provide dividend

Maravai LifeSciences Holdings shares

TickerNameTypeNominal valueISINPrice
MRVI:USMaravai LifeSciences HoldingsCommon share-US56600D1072$7.84
Maravai LifeSciences Holdings news
06.05.2022
Maravai LifeSciences Holdings' GAAP net income for 3 months of 2022 was $146.86 million, up 94.6% from $75.465 million in the previous year. Revenue increased 64.8% to $244.293 million from $148.211 million a year earlier.
Source: {source} pictogram investors.maravai.com
Pictogram next
24.02.2022
Net income of Maravai LifeSciences Holdings under GAAP for 2021 was $469.25 million, up 5.9 times from $78.816 million in the previous year. Revenue increased 2.8 times to $799.24 million from $284.098 million a year earlier.
Source: {source} pictogram investors.maravai.com
Pictogram next
11.11.2021
Maravai LifeSciences Holdings' GAAP net income for 9M 2021 was $343.006 million, up 5.3 times from $64.344 million in the previous year. Revenue increased 2.1 times to $570.796 million from $185.745 million a year earlier.
Source: {source} pictogram investors.maravai.com
Pictogram next
11.08.2021
Maravai LifeSciences Holdings' GAAP net income for 6M 2021 was $210.196 million, up 8.3 times from $25.321 million in the previous year. Revenue increased 3.7 times to $365.986 million from $97.886 million a year earlier.
Source: {source} pictogram investors.maravai.com
Pictogram next
All Maravai LifeSciences Holdings news
General information
Company nameMaravai LifeSciences Holdings
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services
Business address10770 Wateridge Circle Suite 200 San Diego, CA 92121 United States
Mailing address10770 Wateridge Circle Suite 200 San Diego, CA 92121 United States
Websiteinvestors.maravai.com
Information disclosurewww.sec.gov